Madison Square Garden Sports Corp. (MSGS)
NYSECommunication ServicesEntertainmentSnapshot 2026-09-04
$391.16+1.06%
Close 2026-09-04 · 1-day change
NYSECommunication ServicesEntertainmentSnapshot 2026-09-04
Intact: The reason to own it still holds.
Madison Square Garden Sports is improving its operating income, reaching $1.96 million in Q3 2026. Revenue grew to $432.2 million in the same quarter, showing progress in market expansion. The company maintains a $7 dividend per share, supporting shareholder returns.
The company remains loss-making with negative EPS and missed earnings in recent quarters. Revenue growth is weak and analysts expect a 2.6% decline next year. Operating income improvements may not sustain if costs rise or revenue stalls.
The stock price is about 26% above our valuation level, while analysts expect about a 3% revenue decline. Our view is more cautious than the Street, which has higher price targets and expects modest growth.
Breaks if: Dividend falls below $7 per share next quarter
Breaks if: Operating income falls below zero next quarter
Breaks if: Revenue falls below $424 million next quarter
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a long-term thesis focused on a stable business with potential for growth. MSGS is currently loss-making but has shown strong demand for its offerings, particularly in ticketing and media rights for the Knicks and Rangers.
The market appears to be pricing in a fragile situation, with an expensive valuation relative to peers. There is an expectations gap indicating that the current valuation may not fully reflect the company's challenges and recent performance.
Management is focused on completing the spin-off of the Knicks and Rangers, which is expected by October 2026. Recent revenue growth has been strong, but the company has faced some earnings misses, contributing to a moderate risk profile.
The thesis hinges on the performance of sector bellwethers like NFLX, DIS, and WBD, as their results could influence MSGS's momentum. Additionally, management's ability to execute on their priorities, particularly the spin-off, will be crucial.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a positive outlook. The filing for the split of the Knicks and Rangers businesses reinforces this momentum. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the next 1 to 3 years, MSGS's performance will depend on external sector dynamics and internal execution on strategic priorities. Not investment advice.